Aspen Global - M&A Summary and Business Overview

Life ScienceCompany

Aspen Global M&A Summary

Aspen Global has acquired 1 company. It has also divested 2 assets.

Aspen Global’s largest acquisition to date was in 2013, when it acquired GSK s Arixtra Fraxiparine brands for $1.1B. It’s largest disclosed sale occurred in 2019, when it sold Aspen Global - Japanese Operations to Sandoz International for $489M. The Company’s most targeted sectors include medical products (100%).

Aspen Global Business Overview

Where is Aspen Global headquartered?

Aspen Global is headquartered in Grand Bay, Mauritius.

What sector is Aspen Global in?

Aspen Global is a life science company.

When was Aspen Global founded?

Aspen Global was founded in 2008.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity1
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3

Aspen Global, Inc.

301 GBS Plaza cnr La Salette and Royal Roads,
Grand Bay,
Mauritius,
230 269 1111

South African-based Aspen is a supplier of branded and generic pharmaceuticals in more than 150 countries across the world and of consumer and nutritional products in selected territories. Aspen has production capabilities for a wide variety of product types including tablets, capsules, eye drops, injectable products (including lyophilized vials), oral contraceptives, form-filled seals, suppositories, liquids, creams, ointments, infant nutritional products, and specialist active pharmaceutical ingredients.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $1.1B $1.1B
Sell (0.0/yr) # 2 - - - - - 2
vol $540M $540M
  3

Most Recent M&A

Company Date Value Type
Aspen Global, Inc. - Japanese Operations 2019-11-11 489M ZAR Divestiture
, Japan
OTC Products 2014-02-28 51M USD Divestiture
Grand Bay, Mauritius
GSK's Arixtra, Fraxiparine brands 2013-09-30 1.1B GBP Divestiture
, United Kingdom
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 1 (100%) 1.1B (100%) 1 (50%) 51M (9%)
Life Science - - 1 (50%) 489M (91%)
Total 1 $1.1B 2 $540M

By Geo

State/Country Buy Value Sell Value
Japan - - 1 489M
Mauritius - - 1 51M
United Kingdom 1 1.1B - -
Domestic - - 1 (50%) 51M (9%)
Cross-border 1 (100%) 1.1B (100%) 1 (50%) 489M (91%)
Total 1 $1.1B 2 $540M

Deal Values

buy # Total
> $1B 1 $1.1B
TOTAL $1.1B
Largest GSK's Arixtra, Fraxiparine brands
$1.1B (2013-09-30)
sell # Total
$100M to $1B 1 $489M
< $100M 1 $51M
TOTAL $540M
Largest Aspen Global, Inc. - Japanese Operations
$489M (2019-11-11)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)
Divested to
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Aspen Global

Life Science Companies , Mauritius Companies